ImmunityBio (IBRX) Return on Capital Employed (QoQ) (2015 - 2026)
ImmunityBio (IBRX) Return on Capital Employed (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544.00 |
| Dec 31, 2025 | 758.00 |
| Sep 30, 2025 | 2,977.00 |
| Jun 30, 2025 | 1,215.00 |
| Mar 31, 2025 | 141.00 |
| Dec 31, 2024 | -310.00 |
| Sep 30, 2024 | -495.00 |
| Jun 30, 2024 | -1,318.00 |
| Mar 31, 2024 | 160.00 |
| Dec 31, 2023 | 4,492.00 |
| Sep 30, 2023 | -25,900.00 |
| Jun 30, 2023 | -4,726.00 |
| Mar 31, 2023 | -7,229.00 |
| Dec 31, 2022 | 37,599.00 |
| Sep 30, 2022 | -162,058.00 |
| Jun 30, 2022 | 219,475.00 |
| Mar 31, 2022 | -191,338.00 |
| Dec 31, 2021 | 137,940.00 |
| Sep 30, 2021 | 438.00 |
| Jun 30, 2021 | -267.00 |